Market News & Trends
Micropore Technologies Appoints New Sales Development Director for the Americas
UK-based particle engineering specialist Micropore Technologies has just announced the appointment of Dr. Camden Cutright as its new Sales Development Director based in the US.…
BridgeBio Pharma’s Affiliate QED Therapeutics & Helsinn Group Announce Strategic Co-Development & Commercialization Agreement
BridgeBio Pharma, Inc., through its affiliate QED Therapeutics, Inc., and Helsinn Group recently announced a global collaboration and licensing agreement to further develop and commercialize…
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement With AstraZeneca to Include Drug Product Manufacturing
Ajinomoto Bio-Pharma Services recently announced a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing. This agreement expands the scope of Aji Bio-Pharma’s service…
Tarsus Pharmaceuticals & LianBio Announce Strategic Development & Commercialization Partnership
Tarsus Pharmaceuticals, Inc. and LianBio recently announced a strategic partnership to develop and commercialize TP-03 in Greater China (mainland China, Hong Kong, Taiwan, and Macau)…..
Syneos Health Partners With Science 37 to Transform Clinical Trials
Syneos Health and Science 37 recently announced a strategic partnership to enable enhanced decentralized clinical trial delivery…..
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Pfizer Inc. and BioNTech SE recently announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2….
Ajinomoto & Bright Peak Therapeutics Enter Research Collaboration & License Agreement
Ajinomoto Co., Inc. and Bright Peak Therapeutics Inc. recently announced a research collaboration and exclusive license agreement to incorporate AJICAP, Ajinomoto Co.’s proprietary….
PCI Broadens Clinical Trial Service Offerings at Berlin Facility
PCI Pharma Services recently announce a new milestone in its global Clinical footprint with the expansion of cold chain clinical supply storage and distribution capabilities at its….
EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution & Storage of Doses Across European Union
Pfizer Inc. and BioNTech SE recently announced the European Medicines Agency (EMA) approved storage of COMIRNATY at -25°C to -15°C for a total of 2 weeks….
Clinical Trial Data on the Use of Probiotics in Outpatients With COVID-19
Researchers at the Hospital General Manuel Gea González in Mexico City have reported results from a study designed to assess the impact of four specific strains of probiotics on the rate of remission from infection with SARS-CoV-2….
Agios Shareholders Approve Sale of Oncology Business to Servier
Agios Pharmaceuticals, Inc. recently announced its shareholders voted to approve the previously disclosed sale of its commercial, clinical, and research-stage oncology portfolio to….
CureVac’s COVID-19 Vaccine Candidate Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant in Preclinical Challenge Study
CureVac N.V. recently announced the publication of preclinical data demonstrating that their COVID-19 vaccine candidate, CVnCoV, protects against challenge infections with the SARS-CoV-2 Variant of…
Dunad Therapeutics Emerges to Develop Next-Generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology
Dunad Therapeutics recently emerged to develop next-generation small molecule therapeutics based on its highly differentiated, tuneable, and targeted protein degradation technology. Dunad, secured initial financing…
Visus Therapeutics Initiates Phase 2 Clinical Trial for Presbyopia Treatment
Visus Therapeutics Inc. recently announced the commencement of its Phase 2 clinical trial of BRIMOCHOL topical ophthalmic solution under investigation for the treatment of presbyopia.…
AstraZeneca’s & J&J’s COVID-19 Vaccines Manufacturing Face Viral Vector Shortages
The latest wave of COVID-19 vaccines - those from AstraZeneca and Johnson & Johnson (J&J) - are recombinant vector vaccines, which are a different molecule…
Catalent Signs Drug Development Agreement With Cybin Inc
Catalent recently announced it has signed an agreement with Cybin Inc. to apply Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology for the delivery of…
IONTAS Identifies Novel SARS-CoV-2 Neutralizing Antibodies
IONTAS Limited and FairJourney Biologics S.A recently announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. The results, generated from a…
Micropore Appoints Technology Distributor for Japanese Market
Award-winning UK-based particle engineering specialist Micropore Technologies has just announced the appointment of the Mutual Corporation as the representative for sales….
Aptar Pharma & Noble Partner With dne pharma on its Nasal Naloxone Treatment
Aptar Pharma and Noble, an Aptar Pharma company, recently announced their collaboration with dne pharma. Both companies are providing their nasal drug delivery….
Hovione Completes its Phase 2 Clinical Trial of the First Minocycline Ophthalmic
Hovione recently announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused….
